Decreased expression of germinal center-associated nuclear protein is involved in chromosomal instability in malignant gliomas

Cancer Science

Volumn 100, Issue 11, 2009, Pages 2069-2076

  Ohta, Kazutaka ^a   Kuwahara, Kazuhiko ^a   Zhang, Zhenhuan ^a   Makino, Keishi ^a   Komohara, Yoshihiro ^b   Nakamura, Hideo ^a   Kuratsu, Jun Ichi ^a   Sakaguchi, Nobuo ^a,c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GERMINAL CENTER ASSOCIATED NUCLEAR PROTEIN; PHOSPHOPROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CHROMOSOMAL INSTABILITY; CHROMOSOME 10; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SENESCENCE;

ACETYLTRANSFERASES; ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; FEMALE; GENES, P53; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE;

EID: 71049138130     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01293.x     Document Type: Article

References (43)

1. Zhu Y, Parada LE. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002, 2:616-26.
2. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-8.
3. Tada K, Shiraishi S, Kamiryo T. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival. J Neurosurg 2001, 95:651-9.
4. Shinojima N, Tada K, Shiraishi S. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 2003, 63:6962-70.
5. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993, 53:2736-9.
6. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat Genet 2003, 34:369-76.
7. Di Micco R, Fumagalli M, d'Adda di Fagagna F. Breaking news: high-speed race ends in arrest - how oncogenes induce senescence. Trends Cell Biol 2007, 17:529-36.
8. Svejstrup JQ. Mechanisms of transcription-coupled DNA repair. Nat Rev Mol Cell Biol 2002, 3:21-9.
9. Gaillard H, Wellinger RE, Aguilera A. A new connection of mRNP biogenesis and export with transcription-coupled repair. Nucleic Acids Res 2007, 35:3893-906.
10. Fischer T, Strasser K, Racz A. The mRNA export machinery requires the novel Sac3p-Thp1p complex to dock at the nucleoplasmic entrance of the nuclear pores. EMBO J 2002, 21:5843-52.
11. Gallardo M, Luna R, Erdjument-Bromage H, Tempst P, Aguilera A. Nab2p and the Thp1p-Sac3p complex functionally interact at the interface between transcription and mRNA metabolism. J Biol Chem 2003, 278:24225-32.
12. Aguilera A. Cotranscriptional mRNP assembly: from the DNA to the nuclear pore. Curr Opin Cell Biol 2005, 17:242-50.
13. Kuwahara K, Yoshida M, Kondo E. A novel nuclear phosphoprotein, GANP, is up-regulated in centrocytes of the germinal center and associated with MCM3, a protein essential for DNA replication. Blood 2000, 95:2321-8.
14. Kuwahara K, Fujimura S, Takahashi Y. Germinal center-associated nuclear protein contributes to affinity maturation of B cell antigen receptor in T cell-dependent responses. Proc Natl Acad Sci USA 2004, 101:1010-5.
15. Sakaguchi N, Kimura T, Matsushita S. Generation of high-affinity antibody against T cell-dependent antigen in the ganp gene-transgenic mouse. J Immunol 2005, 174:4485-94.
16. Kuwahara K, Tomiyasu S, Fujimura S. Germinal center-associated nuclear protein (GANP) has a phosphorylation-dependent DNA primase activity that is up-regulated in germinal center regions. Proc Natl Acad Sci USA 2001, 98:10279-83.
17. Takei Y, Swietlik M, Tanoue A, Tsujimoto G, Kouzarides T, Laskey R. MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3. EMBO Rep 2001, 2:119-23.
18. Fujimura S, Xing Y, Takeya M. Increased expression of germinal center-associated nuclear protein RNA-primase is associated with lymphomagenesis. Cancer Res 2005, 65:5925-34.
19. Yoshida M, Kuwahara K, Shimasaki T, Nakagata N, Matsuoka M, Sakaguchi N. GANP suppresses DNA recombination, measured by direct-repeat β-galactosidase gene construct, but does not suppress the type of recombination applying to immmunoglobulin genes in mammalian cells. Genes Cells 2007, 12:1205-13.
20. Shiraishi S, Tada K, Nakamura H. Influence of p53 mutations on prognosis of patients with glioblastoma. Cancer 2002, 95:249-57.
21. Kamiryo T, Tada K, Shiraishi S. Analysis of loss of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme. J Neurosurg 2002, 96:815-22.
22. Narita M, Nunez S, Heard E. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-16.
23. Nitta M, Tsuiki H, Arima Y. Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability. Genes Cells 2002, 7:151-62.
24. Tsuiki H, Nitta M, Tada M. Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. Oncogene 2001, 20:420-9.
25. Hong FD, Chen J, Donovan S. Taxol, vincristine or nocodazole induces lethality in G1-checkpoint-defective human astrocytoma U373MG cells by triggering hyperploid progression. Carcinogenesis 1999, 20:1161-8.
26. Nishizaki T, Harada K, Kubota H. Chromosomal instability in malignant astrocytic tumors detected by fluorescence in situ hybridization. J Neurooncol 2002, 56:159-65.
27. Nishizaki T, Kubota H, Harada K. Clinical evidence of distinct subgroups of astrocytic tumors defined by comparative genomic hybridization. Hum Pathol 2000, 31:608-14.
28. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396:643-9.
29. Saito T, Hama S, Izumi H. Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity. Br J Cancer 2008, 98:345-55.
30. Inoue T, Hiratsuka M, Osaki M. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene 2007, 26:945-57.
31. Luna R, Jimeno S, Marín M, Huertas P, García-Rubio M, Aguilera A. Interdependence between transcription and mRNP processing and export, and its impact on genetic stability. Mol Cell 2005, 18:711-22.
32. Huertas P, Aguilera A. Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol Cell 2003, 12:711-21.
33. Di Leonardo A, Khan SH, Linke SP. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res 1997, 57:1013-9.
34. Khan SH, Wahl GM. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res 1998, 58:396-401.
35. Finkel T, Serrano M, Blasco MA. The common biology of cancer and aging. Nature 2007, 448:767-74.
36. Mooi WJ, Peeper DS. Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 2006, 355:1037-46.
37. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998, 1378:F115-77.
38. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-12.
39. Zhang R, Poustovoitov MV, Ye X. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 2005, 8:19-30.
40. EL-Gazzar MA, Maeda K, Nomiyama H, Nakao M, Kuwahara K, Sakaguchi N. PU.1 is involved in the regulation of B lineage-associated and developmental stage-dependent expression of the germinal center-associated DNA primase GANP. J Biol Chem 2001, 276:48000-8.
41. Takahashi Y, Rayman JB, Dynlacht BD. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and progression. Genes Dev 2000, 14:804-16.
42. Mitlianga PG, Kyritsis AP, Gomez-Manzano C. Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells. Int J Oncol 2001, 18:343-7.
43. Wang C-C, Liao Y-P, Mischel PS, Iwamoto KS, Cacalano NA, McBride WH. HDJ-2 as target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Cancer Res 2006, 66:6756-62.